COMPASS THERAPEUTICS INC's ticker is CMPX and the CUSIP is 20454B104. A total of 56 filers reported holding COMPASS THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $44,054,815 | -38.1% | 22,362,850 | 0.0% | 0.94% | -27.4% |
Q2 2023 | $71,113,863 | -2.8% | 22,362,850 | 0.0% | 1.29% | -10.2% |
Q1 2023 | $73,126,520 | -35.0% | 22,362,850 | 0.0% | 1.44% | -33.3% |
Q4 2022 | $112,485,136 | +124.7% | 22,362,850 | +1.8% | 2.15% | +131.6% |
Q3 2022 | $50,071,000 | -14.0% | 21,960,850 | 0.0% | 0.93% | -11.9% |
Q2 2022 | $58,196,000 | +96.3% | 21,960,850 | +1.5% | 1.06% | +119.3% |
Q1 2022 | $29,651,000 | -56.8% | 21,642,975 | 0.0% | 0.48% | -45.5% |
Q4 2021 | $68,608,000 | – | 21,642,975 | – | 0.88% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management V, LLC | 1,246,977 | $2,456,545 | 3.92% |
CHI Advisors LLC | 2,829,712 | $5,574,532 | 2.21% |
Ally Bridge Group (NY) LLC | 914,630 | $1,801,821 | 2.12% |
Monashee Investment Management LLC | 1,226,142 | $2,415,500 | 1.01% |
Orbimed Advisors | 22,362,850 | $44,054,815 | 0.94% |
Vivo Capital, LLC | 3,556,023 | $7,005,365 | 0.77% |
CAXTON CORP | 86,773 | $170,942 | 0.65% |
Prosight Management, LP | 935,157 | $1,842,259 | 0.58% |
BRAIDWELL LP | 5,954,273 | $11,729,918 | 0.37% |
Rock Springs Capital Management LP | 5,513,788 | $10,862,162 | 0.29% |